NIAGEN BIOSCIENCE, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
NIAGEN BIOSCIENCE, INC. (NAGE) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 17.95 thousand shares for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2017-11-09
- NIAGEN BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-09-30 was 17.95K shares.
- NIAGEN BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-07-01 was 0.00 shares.
- NIAGEN BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2017-04-01 was 0.00 shares, a 100.00% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2016-10-01 was 0.00 shares.
- NIAGEN BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2013 was 605.57K shares, a 89.41% decline from fiscal 2012.
- NIAGEN BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2012 was 5.72M shares, a 25.50% decline from fiscal 2011.
- NIAGEN BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2011 was 7.68M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 9 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|---|
| 2017-09-30 | 17.95K shares 10-Q · filed 2017-11-09 | 0.00 shares 10-Q · filed 2017-11-09 | ||
| 2017-07-01 | 0.00 shares 10-Q · filed 2017-08-10 | 0.00 shares 10-Q · filed 2017-08-10 | ||
| 2017-04-01 | 0.00 shares 10-Q · filed 2017-05-11 | |||
| 2016-10-01 | 0.00 shares 10-Q · filed 2017-11-09 | 0.00 shares 10-Q · filed 2017-11-09 | ||
| 2016-07-02 | 0.00 shares 10-Q · filed 2017-08-10 | 41.75K shares 10-Q · filed 2017-08-10 | ||
| 2016-04-02 | 34.11K shares 10-Q · filed 2017-05-11 | |||
| 2014-03-29 | 4.86M shares 10-Q · filed 2014-05-08 | |||
| 2013-12-28 | 605.57K shares 10-K · filed 2014-03-27 | |||
| 2013-09-28 | 577.19K shares 10-Q · filed 2013-11-21 | 312.53K shares 10-Q · filed 2013-11-21 | ||
| 2013-06-29 | 319.59K shares 10-Q/A · filed 2013-12-05 | 256.02K shares 10-Q/A · filed 2013-12-05 | ||
| 2013-03-30 | 3.30M shares 10-Q · filed 2014-05-08 | |||
| 2012-12-29 | 5.72M shares 10-K · filed 2014-03-27 | |||
| 2012-09-29 | 5.99M shares 10-Q · filed 2013-11-21 | 5.91M shares 10-Q · filed 2013-11-21 | ||
| 2012-06-30 | 5.69M shares 10-Q/A · filed 2013-12-05 | 6.10M shares 10-Q/A · filed 2013-12-05 | ||
| 2012-03-31 | 6.58M shares 10-Q/A · filed 2013-12-05 | |||
| 2011-12-31 | 7.68M shares 10-K · filed 2013-03-29 | |||
| 2011-10-01 | 7.67M shares 10-Q · filed 2012-11-08 | 7.89M shares 10-Q · filed 2012-11-08 | ||
| 2011-07-02 | 14.53M shares 10-Q/A · filed 2012-08-10 | 15.18M shares 10-Q/A · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |